Conference Reports for NATAP
HIV Glasgow 2026
8-11 November
Back
 
Tweet
Long-term effectiveness of long-acting cabotegravir/rilpivirine in people with HIV harboring non-rilpivirine NNRTI resistance mutations: two-year results from the RELATIVITY cohort
Glasgow 2026 Nov 8-11
David Rial-Crestelo